Literature DB >> 8500911

Expression of contact-dependent cytolytic activity by Mycobacterium tuberculosis and isolation of the genomic locus that encodes the activity.

C H King1, S Mundayoor, J T Crawford, T M Shinnick.   

Abstract

We investigated the presence of cytolytic activity in the virulent H37Rv and attenuated H37Ra strains of Mycobacterium tuberculosis and in the vaccine strain Mycobacterium bovis BCG. The virulent strain H37Rv expressed > 3-fold more contact-dependent cytolytic activity than the attenuated strain H37Ra, and the vaccine strain M. bovis BCG did not produce cytolytic activity. We also isolated an approximately 3.2-kbp fragment of the M. tuberculosis H37Rv genome that was capable of inducing this contact-dependent hemolytic activity in a nonhemolytic strain of Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500911      PMCID: PMC280905          DOI: 10.1128/iai.61.6.2708-2712.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Pore-forming cytolysins of gram-negative bacteria.

Authors:  R A Welch
Journal:  Mol Microbiol       Date:  1991-03       Impact factor: 3.501

Review 2.  Tuberculosis in patients with human immunodeficiency virus infection.

Authors:  P F Barnes; A B Bloch; P T Davidson; D E Snider
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

3.  Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis.

Authors:  A Rogel; R Meller; E Hanski
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

4.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.

Authors:  L S Schlesinger; C G Bellinger-Kawahara; N R Payne; M A Horwitz
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

Review 5.  Tuberculosis in developing countries: burden, intervention and cost.

Authors:  C J Murray; K Styblo; A Rouillon
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1990-03

6.  A novel bicomponent hemolysin from Bacillus cereus.

Authors:  D J Beecher; J D MacMillan
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

7.  Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation.

Authors:  P Cossart; M F Vicente; J Mengaud; F Baquero; J C Perez-Diaz; P Berche
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

8.  Intracellular hemolysin-producing Listeria monocytogenes strains inhibit macrophage-mediated antigen processing.

Authors:  C W Cluff; M Garcia; H K Ziegler
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

9.  Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.

Authors:  S Bhakdi; M Muhly; S Korom; G Schmidt
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

10.  Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.

Authors:  A J Crowle; R Dahl; E Ross; M H May
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

View more
  34 in total

1.  Temporal pore formation-mediated egress from macrophages and alveolar epithelial cells by Legionella pneumophila.

Authors:  O A Alli; L Y Gao; L L Pedersen; S Zink; M Radulic; M Doric; Y Abu Kwaik
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Disconnecting in vitro ESX-1 secretion from mycobacterial virulence.

Authors:  Patricia A DiGiuseppe Champion
Journal:  J Bacteriol       Date:  2013-10-11       Impact factor: 3.490

3.  Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes.

Authors:  J Hess; D Miko; A Catic; V Lehmensiek; D G Russell; S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  A Nonsense Mutation in Mycobacterium marinum That Is Suppressible by a Novel Mechanism.

Authors:  Emily A Williams; Felix Mba Medie; Rachel E Bosserman; Benjamin K Johnson; Cristal Reyna; Micah J Ferrell; Matthew M Champion; Robert B Abramovitch; Patricia A Champion
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

5.  Surface hydrolysis of sphingomyelin by the outer membrane protein Rv0888 supports replication of Mycobacterium tuberculosis in macrophages.

Authors:  Alexander Speer; Jim Sun; Olga Danilchanka; Virginia Meikle; Jennifer L Rowland; Kerstin Walter; Bradford R Buck; Mikhail Pavlenok; Christoph Hölscher; Sabine Ehrt; Michael Niederweis
Journal:  Mol Microbiol       Date:  2015-07-04       Impact factor: 3.501

6.  Esx Paralogs Are Functionally Equivalent to ESX-1 Proteins but Are Dispensable for Virulence in Mycobacterium marinum.

Authors:  Rachel E Bosserman; Cristal Reyna Thompson; Kathleen R Nicholson; Patricia A Champion
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

7.  Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion.

Authors:  L Ramakrishnan; S Falkow
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis.

Authors:  K A McDonough; Y Kress
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  The Mycobacterium tuberculosis phagosome in human macrophages is isolated from the host cell cytoplasm.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Molecular characterization of tlyA gene product, Rv1694 of Mycobacterium tuberculosis: a non-conventional hemolysin and a ribosomal RNA methyl transferase.

Authors:  Aejazur Rahman; Saumya S Srivastava; Amita Sneh; Neesar Ahmed; Musti V Krishnasastry
Journal:  BMC Biochem       Date:  2010-09-20       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.